Valentina Granata

Dr. Valentina Granata

IRCCS Humanitas Research Hospital, Rozzano, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

Verified
Journal Article
Open access
PDF file
VGValentina Granata
Valentina Granata
IPIsabel Pagani
Isabel Pagani
EMEmanuela Morenghi
Emanuela Morenghi
MSMaria lucia schiavone
Maria lucia schiavone
ALAlessandra Lezzi
Alessandra Lezzi
CSCristina Sobacchi
Cristina Sobacchi
Upon infection, severe acute respiratory syndrome—coronavirus 2 (SARS-CoV-2) is predicted to interact with diverse cellular functions, such as the nonsense-mediated decay (NMD) pathway, as suggested by the identification of the core NMD factor upframeshift-1 (UPF1) in the SARS-CoV-2 interactome, and the retrograde transport from the Golgi to the endoplasmic reticulum (ER) through the endoplasmic reticulum–Golgi intermediate compartment (ERGIC), where coronavirus assembly occurs. Here, we investigated the expression and localization of the neuroblastoma-amplified sequence (NBAS) protein, a UPF1 partner for the NMD at the ER, participating also in retrograde transport, and of its functional partners, at early time points after SARS-CoV-2 infection of the human lung epithelial cell line Calu3. We found a significant decrease of DExH-Box Helicase 34 (DHX34), suppressor with morphogenetic effect on genitalia 5 (SMG5), and SMG7 expression at 6 h post-infection, followed by a significant increase of these genes and also UPF1 and UPF2 at 9 h post-infection. Conversely, NBAS and other genes coding for NMD factors were not modulated. Known NMD substrates related to cell stress (Growth Arrest Specific 5, GAS5; transducin beta-like 2, TBL2; and DNA damage-inducible transcript 3, DDIT3) were increased in infected cells, possibly as a result of alterations in the NMD pathway and of a direct effect of the infection. We also found that the expression of unconventional SNARE in the ER 1, USE1 (p31) and Zeste White 10 homolog, ZW10, partners of NBAS in the retrograde transport function, significantly increased over time in infected cells. Co-localization of NBAS and UPF1 proteins did not change within 24 h of infection nor did it differ in infected versus non-infected cells at 1 and 24 h after infection; similarly, the co-localization of NBAS and p31 proteins was not altered by infection in this short time frame. Finally, both NBAS and UPF1 were found to co-localize with SARS-CoV-2 S and N proteins. Overall, these data are preliminary evidence of an interaction between NBAS and NBAS-related functions and SARS-CoV-2 in infected cells, deserving further investigation.

8 May 2024 in Genes
Verified
Journal Article
Open access
PDF file
VGValentina Granata
Valentina Granata
DSDario Strina
Dario Strina
VPValentina Possetti
Valentina Possetti
RLRoberto Leone
Roberto Leone
SVSonia Valentino
Sonia Valentino
AIAntonio Inforzato
Antonio Inforzato
Periprosthetic joint infections (PJIs) are serious complications of prosthetic surgery. The criteria for the diagnosis of PJI integrate clinical and laboratory findings in a complex and sometimes inconclusive workflow. Host immune factors hold potential as diagnostic biomarkers in bone and joint infections. We reported that the humoral pattern-recognition molecule long pentraxin 3 (PTX3) predicts PJI in total hip and knee arthroplasty (THA and TKA, respectively). If and how genetic variation in PTX3 and inflammatory genes that affect its expression (IL-1β, IL-6, IL-10, and IL-17A) contributes to the risk of PJI is unknown. We conducted a case–control study on a Caucasian historic cohort of THA and TKA patients who had prosthesis explant due to PJI (cases) or aseptic complications (controls). Saliva was collected from 93 subjects and used to extract DNA and genotype PTX3, IL-1β, IL-6, IL-10, and IL-17A single-nucleotide polymorphisms (SNPs). Moreover, the concentration of IL-1β, IL-10, and IL-6 was measured in synovial fluid and plasma. No association was found between PTX3 polymorphisms and PJI; however, the AGG haplotype, encompassing rs2853550, rs1143634, and rs1143627 in IL-1β, was linked to the infection (p = 0.017). Also, synovial levels of all inflammatory markers were higher in cases than in controls, and a correlation emerged between synovial concentration of PTX3 and that of IL-1β in cases only (Spearman r = 0.67, p = 0.004). We identified a relationship between rs2853550 and the synovial concentration of IL-1β and PTX3. Our findings suggest that IL-1β SNPs could be used for the early identification of THA and TKA patients with a high risk of infection.

Verified
Journal Article
Open access
PDF file
VGValentina Granata
Valentina Granata
DSDario Strina
Dario Strina
MSMaria lucia schiavone
Maria lucia schiavone
BBBarbara Bottazzi
Barbara Bottazzi
Alberto MantovaniAlberto Mantovani
Alberto Mantovani
CSCristina Sobacchi
Cristina Sobacchi
The long pentraxin 3 (PTX3) is a soluble glycoprotein made by immune and nonimmune cells endowed with pleiotropic functions in innate immunity, inflammation, and tissue remodeling. PTX3 has recently emerged as a mediator of bone turnover in both physiological and pathological conditions, with direct and indirect effects on osteoblasts and osteoclasts. This notwithstanding, its role in bone biology, with major regard to the osteogenic potential of osteoblasts and their interplay with osteoclasts, is at present unclear. Here, we investigated the contribution of this pentraxin to bone deposition in the osteogenic lineage by assessing collagen production, mineralization capacity, osteoblast maturation, extracellular matrix gene expression, and inflammatory mediators’ production in primary osteoblasts from the calvaria of wild-type (WT) and Ptx3-deficient (Ptx3−/−) mice. Also, we evaluated the effect of PTX3 on osteoclastogenesis in cocultures of primary osteoblasts and bone marrow-derived osteoclasts. Our investigations were carried out both in physiological and inflammatory conditions to recapitulate in vitro aspects of inflammatory diseases of the bone. We found that primary osteoblasts from WT animals constitutively expressed low levels of the protein in osteogenic noninflammatory conditions, and genetic ablation of PTX3 in these cells had no major impact on collagen and hydroxyapatite deposition. However, Ptx3−/− osteoblasts had an increased RANKL/OPG ratio and CD44 expression, which resulted in in enhanced osteoclastogenesis when cocultured with bone marrow monocytes. Inflammation (modelled through administration of tumor necrosis factor-α, TNF-α) boosted the expression and accumulation of PTX3 and inflammatory mediators in WT osteoblasts. In these conditions, Ptx3 genetic depletion was associated with reduced collagen deposition and immune modulators’ production. Our study shed light on the role of PTX3 in osteoblast and osteoclast biology and identified a major effect of inflammation on the bone-related properties of this pentraxin, which might be relevant for therapeutic and/or diagnostic purposes in musculoskeletal pathology.

25 October 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ATAntonio Tonutti
Antonio Tonutti
VGValentina Granata
Valentina Granata
VMVeronica Agata Marrella
Veronica Agata Marrella
CCChiara Camisaschi
Chiara Camisaschi
SPSimone Puccio
Simone Puccio
ACAngela Ceribelli
Angela Ceribelli
Innate and adaptive immunity, oxidative stress and altered bone remodeling have been implicated in the pathogenesis of knee osteoarthritis (OA). Intra-articular blood-derived orthobiologic treatments (broadly defined within the umbrella term platelet-rich plasma - PRP) represent a conservative therapeutic approach, yet reliable predictors of treatment response remain elusive. Multimodal profiling of peripheral blood may help identify responders to PRP. Patients aged 40-70 years with Kellgren-Lawrence grade 2-3 knee OA, no history of inflammatory arthritis, and a BMI < 40 kg/m² received a single knee PRP injection. Prior to treatment, peripheral blood was collected to assess gene and protein expression of inflammatory and bone remodeling molecules, and antioxidant capacity. Multiparametric flow cytometry with cluster analysis was also performed to identify immune cell subsets. Treatment response was assessed six months post-injection using the WOMAC questionnaire. Among 55 patients, 45 were responders, with no differences in age, sex, or disease duration compared to non-responders. Responders exhibited a higher peripheral blood inflammatory signature, including upregulation of IL-1, IL-6, and TNF signaling pathways, increased RANKL and SFRP3 expression. Serum levels of ascorbic acid and 4-hydroxynonenal were more elevated in PRP responders. Flow cytometry identified populations of CD4⁺ T cells (expressing HLA-DR, CD95, and PD-1) and CD8⁺ T cells (expressing CD25 and CCR7), which were differentially represented between PRP responders and non-responders. Early response to autologous blood-derived orthobiologic injections could be associated with specific inflammatory and oxidative stress markers and distinct peripheral blood T cell phenotypes of patients undergoing treatment. Further studies are warranted to validate these findings in larger cohorts at extended follow-up timepoints.

22 November 2024 in Orthopaedic Proceedings
Verified
Journal Article
Closed access
VGValentina Granata
Valentina Granata
DSDario Strina
Dario Strina
VPValentina Possetti
Valentina Possetti
RLRoberto Leone
Roberto Leone
SVSonia Valentino
Sonia Valentino
AIAntonio Inforzato
Antonio Inforzato
Aim: Periprosthetic joint infection (PJI) is one of the most serious and frequent complications in prosthetic surgery. Despite significant improvements in the criteria for diagnosis of PJI, the diagnostic workflow remains complex and, sometimes, inconclusive. Host immune factors hold great potential as diagnostic biomarkers in bone and joint infections. We have recently reported that the synovial concentration of the humoral pattern recognition molecule long pentraxin 3 (PTX3) is a sensitive and specific marker of PJI in total hip and knee arthroplasty patients (THA and TKA) undergoing revision surgery [1]. However, the contribution to risk and diagnosis of PJI of the genetic variation in PTX3 and inflammatory genes that are known to affect its expression (IL-1b, IL-6, IL-10, and IL-17A) has not been addressed. Therefore, we assessed these relationships in a cohort of THA and TKA patients who underwent prosthesis revision by focusing on a panel of single nucleotide polymorphisms (SNPs) in the PTX3, IL-1β, IL-6, IL-10 and IL-17A genes.Method: A case-control retrospective study was conducted on an historic cohort of patients that received THA or TKA revision and were diagnosed with PJI (cases) or aseptic complications (controls) [1]. Samples of saliva were collected from 93 subjects and used for extraction of genomic DNA to perform genotyping of the PTX3, IL-1β, IL-6, IL-10 and IL-17A polymorphisms. Moreover, whenever available, samples of synovial fluid and plasma [1] were used to measure the concentration of the IL-1β, IL-10, and IL-6 proteins by immunoassay. Uni-and multivariate analyses were performed to evaluate the relationships between genetic, biochemical, and clinical variables.Results: The rs3024491 (IL-10) and rs2853550 (IL-1b) SNPs were found to be strongly associated with the risk of PJI. The synovial levels of PTX3, IL-1β, IL-10, and IL-6 were higher in cases than in controls, and a clear correlation emerged between the synovial concentration of PTX3 and IL-1b in cases only. Also, we identified a causal relationship between rs2853550, synovial concentration of IL-1b and that of PTX3 (that is induced by IL-1b).Conclusions: Our findings suggest that SNPs in the IL-10 and IL-1b genes could be used for early identification of THA and TKA patients with high risk of PJI. It is therefore conceivable that integrating genetic data into current diagnostic criteria would improve diagnosis of PJI.